Page 73 - Lipids News Today

Lipids Market Size Forecast To Reach US$17.3 Billion by 2027

Researchers reviewed the material properties and administration routes that could successfully deliver a messenger ribonucleic acid therapeutic agent to its targeted site.

Rosuvastatin, simvastatin, and atorvastatin were most effective in reducing levels of non-high-density-lipoprotein cholesterol in people with diabetes in a network meta-analysis of 42 clinical trials.

Medicare beneficiaries without a low-income subsidy are much less likely to fill high-price drug prescriptions to treat cancer and other conditions because of out-of-pocket costs.

Alzheimer's Disease could be caused by damage to a protective barrier in the body that allows fatty substances to build up in the brain, newly published research argues.

An improved government and private sector should be in place if the Philippines wants to recover from the pandemic and grow inclusively.

An observational study shows statins are linked to a lower risk of age-related parkinsonism that may be partially mediated by less severe intracranial atherosclerosis.

The European Association of Preventive Cardiology cites the bidirectional relationship of heart failure and depression and stresses the need to address patients psychological needs.

A team led by University of Minnesota Twin Cities engineering researchers analyzed the fundamental properties and structures of lung surfactant-;a naturally occurring substance that helps human and animal lungs expand and contract-;providing insight that could eventually help scientists develop better treatments for respiratory illnesses.

People with diabetic retinopathy who took the cholesterol-lowering drug fenofibrate were less likely to progress to vision-threatening forms of the disease, in a large database study.